Traws Pharma, Inc. TRAW

0.56 0.00 0.00% as of 25 Sep
Market cap
$7.3M
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
3.82 21.34 20.82 38.76 55.07 19.03 22.73 16.97 4.02 21.45
Receivables
3.79 1.77 0.02 0.03 0.03 0.04 0.10 0.04 0.06 0.03
Total current assets
7.98 24.95 22.66 39.35 55.43 19.78 23.47 17.77 4.90 23.07
Property, Plant, Equpment (Net)
0.01 0.01 0.02 0.02 0.04 0.05 0.05 0.01 0.06 0.15
Goodwill and Intangible Assets (Total)
2.53 — — — — — — — — —
Long-term assets (Other)
0.10 0.00 0.00 0.00 0.01 0.15 0.15 0.15 0.01 0.01
Total non-current assets
2.64 0.01 0.02 0.03 0.05 0.20 0.20 0.16 0.08 0.16
Total Assets
10.62 24.96 22.68 39.37 55.48 19.99 23.67 17.92 4.98 23.23
Accounts Payable
5.65 8.19 5.62 3.86 2.76 4.83 4.27 4.04 6.19 5.32
Accrued Expenses
5.49 3.12 3.38 3.96 3.13 4.96 3.80 4.17 3.34 4.38
Current Revenue (Deferred)
— 0.23 0.23 0.23 0.23 0.23 0.23 0.23 0.46 0.46
Total current liabilities
11.15 11.53 9.22 8.05 6.12 10.02 8.29 8.44 9.98 10.16
Non-current Revenue (Deferred)
0.00 2.57 2.79 3.02 3.24 3.47 3.70 3.92 4.09 4.55
Non-current Liabilities (Other)
0.10 42.49 — — — 0.32 0.11 0.18 1.77 3.40
Total non-current liabilities
0.10 45.06 2.79 3.02 3.24 3.79 3.81 4.10 5.86 7.95
Total liabilities
11.25 56.59 12.01 11.06 9.36 13.81 12.10 12.54 15.84 18.11
Additional Paid In Capital
639.26 617.53 493.32 491.82 490.64 434.59 413.88 387.24 350.61 342.48
Common Stock (Net)
0.09 0.04 0.01 0.21 0.21 0.12 1.11 0.06 0.01 0.07
Retained Earnings
(639.98) (649.15) (482.63) (463.68) (444.72) (428.56) (403.40) (381.90) (362.32) (338.22)
Common Equity (Total)
(0.63) (31.63) 10.67 28.31 46.12 6.18 11.57 5.39 (10.86) 5.13
Shareholders Equity (Total)
(0.63) (31.63) 10.67 28.31 46.12 6.18 11.57 5.39 (10.86) 5.13
Shareholders Equity and Liabilities (Total)
10.62 24.96 22.68 39.37 55.48 19.99 23.67 17.92 4.98 23.23
Shares (Common)
9.07 3.65 0.84 0.84 0.84 0.50 0.30 0.02 0.00 0.00
Shares (Preferred)
0.01 0.01 0.00 — — — — — — —
Shareholders Equity (Tangible)
(3.16) (31.63) 10.67 28.31 46.12 6.18 11.57 5.39 (10.86) 5.13
Net Debt
(3.82) (21.34) (20.82) (38.76) (55.07) (19.02) (22.73) (16.97) (4.02) (21.45)

Fold the line items

In millions of $ except per-share values · columns are period end dates